Author:
Sakayori Takeshi,Ikeda Yumiko,Arakawa Ryosuke,Nogami Tsuyoshi,Tateno Amane
Funder
the Japan Sports Agency Ministry of Education, Culture, Sports, Science and Technology-Japan
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Chiamulera, C. Research is needed on the use of cognitive enhancer drugs in sport. J. Sci. Med. Sport. 14, 2–3 (2011).
2. World Anti-Doping Agency. World anti-doping code: Prohibited list 2024. https://www.wada-ama.org/sites/default/files/2023-09/2024list_en_final_22_september_2023.pdf (2024).
3. Dela Pena, I., Gevorkiana, R. & Shi, W. Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. Eur. J. Pharmacol. 764, 562–570 (2015).
4. Loi, B., Sahai, M. A., De Luca, M. A., Shiref, H. & Opacka-Juffry, J. The role of dopamine in the stimulant characteristics of novel psychoactive substances (NPS)-neurobiological and computational assessment using the case of desoxypipradrol (2-DPMP). Front. Pharmacol. 11, 806 (2020).
5. Greenhill, L. L. The science of stimulant abuse. Pediatr. Ann. 35, 552–556 (2006).